Compare ALLO & CAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALLO | CAN |
|---|---|---|
| Founded | 2017 | 2013 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 539.4M | 486.0M |
| IPO Year | 2018 | 2019 |
| Metric | ALLO | CAN |
|---|---|---|
| Price | $2.44 | $0.45 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 8 |
| Target Price | ★ $8.40 | $3.09 |
| AVG Volume (30 Days) | 4.3M | ★ 9.1M |
| Earning Date | 03-12-2026 | 02-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.09 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $140,929.80 | $63.64 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.86 | $0.43 |
| 52 Week High | $2.80 | $2.22 |
| Indicator | ALLO | CAN |
|---|---|---|
| Relative Strength Index (RSI) | 55.11 | 37.21 |
| Support Level | $2.20 | $0.43 |
| Resistance Level | $2.76 | $0.55 |
| Average True Range (ATR) | 0.20 | 0.03 |
| MACD | -0.06 | 0.00 |
| Stochastic Oscillator | 56.06 | 16.10 |
Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.
Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment and the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts and accessories. Geographically, the company derives its maximum revenue from United States.